image: The scientists used CRISPR-Cas9 to target pulmonary epithelial cells (blue), and observed cells were successfully gene-edited (green). This material relates to a paper that appeared in the Apr. 17, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by y D. Alapati at Nemours Alfred I duPont Hospital for Children in Wilmington, DE; and colleagues was titled, "In utero gene editing for monogenic lung disease." view more
Credit: D. Alapati<i> et al., Science Translational Medicine </i>(2019)